InvestorsHub Logo
Followers 1615
Posts 121383
Boards Moderated 3
Alias Born 07/09/2003

Re: RIGATONI post# 367142

Wednesday, 05/04/2022 10:00:20 AM

Wednesday, May 04, 2022 10:00:20 AM

Post# of 383699
Still a hidden Gem with those numbers reported...


Outstanding Shares
37,667,581
04/11/2022

Forward events too..

"We are currently meeting multiple government and private needs for testing related to the COVID-19 pandemic. This includes our participation in the federal government's Test-to-Treat program. In addition, with the launch of our international clinical trial program for medical device manufacturers needing to file either an Emergency Use Authorization (EUA) or a 510K clearance with the FDA, we've reached a new plateau in our range of offered services that we believe will carry us well into the future.

"We also are preparing the launch of a new line of supplements to boost immune systems specifically targeting colds, flu, inflammation and cell mutations. While this is a highly competitive business, we believe our trusted position in the market as a company with an A+ Better Business Bureau rating gives us valuable competitive advantages," Govatski said.

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.